Paige

Missed yesterday’s webinar on Connected Pathology: Revolutionizing Pathology Workflows with AI? The recording is now available! Watch on demand: https://lnkd.in/gfGA7U3F Or, if you're attending USCAP - United States and Canadian Academy of Pathology, experience it firsthand! Stop by Booth #429 for a hands-on demonstration of Paige Alba? and our new AI-assisted GI Suite!

Most AI solutions on the market today focus on individual tissue types, limiting their impact on a pathologist’s true workflow. With the Paige GI Suite, we’re changing that. This first-of-its-kind system-wide AI solution supports pathologists across the entire GI tract, detecting and grading over 40 GI conditions to provide a more comprehensive, pathology-driven approach. What makes this possible? Virchow2, our state-of-the-art foundation model, enables us to develop system-wide diagnostic applications that align with how pathologists actually work. By integrating AI-powered analysis across multiple organs, we’re creating a seamless workflow that enhances efficiency, prioritizes critical cases, and supports more confident diagnoses.

Introducing Paige’s newest AI-assisted diagnostic application, the Paige GI Suite—the first system-wide diagnostic solution for GI pathology. Designed to assist pathologists in detecting and grading over 40 GI conditions, ranging from inflammatory diseases to dysplasia and malignancies, across the esophagus, stomach, duodenum, and colorectum.

Don’t miss Monday’s webinar with Paige & PathPresenter on the future of connected pathology & AI integration! Join Rajendra Singh MD of PathPresenter and our Medical Vice President, Juan Antonio Retamero, as they explore how seamless interoperability between LIS systems, digital pathology platforms, and AI tools is transforming workflows and enhancing efficiency. Attendees will also get an exclusive first look at Paige’s new AI suite and a live demo of Paige Alba? — both integrated into PathPresenter! ?? March 17 | 11:00 AM ET Don’t miss out—register now to secure your spot:?https://lnkd.in/eWp9B7bd

Recently Published CONFIDENT-P Study Highlights the Clinical Impact of AI in Pathology! A prospective clinical trial published in the Journal of Clinical Cancer Informatics, an American Society of Clinical Oncology (ASCO) journal, demonstrates the value of AI in prostate cancer detection. The study, conducted at UMC Utrecht, evaluated the real-world clinical implementation of Paige Prostate Detect and found that AI assistance significantly reduced the need for immunohistochemistry (IHC) while maintaining diagnostic safety standards. Key study highlights: ?? 45% reduction in IHC use ?? Higher diagnostic confidence among AI-assisted pathologists ?? Maintained diagnostic safety, supporting AI’s role in clinical workflows This independent study reinforces the potential of AI to enhance efficiency, optimize resource use, and support pathologists in delivering accurate, timely diagnoses! Read the full study: https://lnkd.in/e2CBzxyi

That’s a wrap on #HIMSS25! Earlier today, our CEO & CTO, Razik Yousfi, led a theater presentation on Paige Alba?, our clinical AI co-pilot, and the future of integrated diagnostics, highlighting how AI is transforming clinical workflows and accelerating cancer detection. The excitement around Alba has been inspiring. It’s clear that the future of precision medicine lies in integrating AI-driven insights across healthcare, and we’re eager to get this technology into the hands of clinicians who are shaping the future. A special thank you to our partners at Microsoft for Healthcare and to everyone who stopped by the booth, engaged in discussions, and shared in our excitement!

Seamless integration is the future of pathology! Join Paige and PathPresenter for a live webinar exploring how AI, LIS systems, and digital pathology platforms are transforming the pathology workflows of today. Connected Pathology: The Power of AI and Integration ?? March 17, 2025 | 11:00 AM ET Plus, get an exclusive first look at Paige’s newest AI suite! Register now: https://lnkd.in/evz56dgY

Fragmented diagnostics cause unnecessary delays in cancer care. Paige is committed to addressing these challenges through AI-driven innovation that enhances efficiency, improves collaboration, and provides clinicians with the insights needed to make informed decisions. Join our CEO & CTO, Razik Yousfi, for a theater presentation at the Microsoft for Healthcare booth #2221 to explore how AI is redefining cancer detection and clinical decision-making: AI-Powered Pathology: Accelerating Cancer Diagnosis with Paige Alba? Clinical Insights on Thursday, March 6 | 12:30 PM PT

The countdown to #HIMSS25 is on! Visit us in the Microsoft for Healthcare booth #2221 and see how we are partnering to help empower your healthcare workforce, unlock more value from clinical data, and accelerate discovery and development. We have exciting new updates to Paige Alba, our clinical AI-copilot, stop by to get an exclusive first look! ? #MSFTHealth #MicrosoftPartners #PartnersMakeMorePossible

Artificial intelligence in pathology has grown smarter, faster, and more powerful—and 2025 will undoubtedly be a breakthrough year for more AI adoption in clinical labs. In a recent article for Today's Clinical Lab, our CEO & CTO, Razik Yousfi, outlines the key drivers of AI adoption: ?? Increased AI integration across pathology labs ?? Seamless interoperability between AI and lab platforms ?? Commitment to responsible AI and ethical innovation With AI-powered pathology foundation models, pre-built modules, diagnostic applications, and clinical co-pilots, labs can benefit from integrated diagnostics to transform their cancer workflows—improving speed, accuracy, and efficiency. Read more about what’s next: https://lnkd.in/eS4uW6jZ